Overview
KBI Biopharma is the CDMO of choice for complex biologics and expert analytics, helping life science companies accelerate the development and manufacture of innovative therapies and vaccines. With roots in analytical services and deep technical expertise in mammalian and microbial programs, KBI provides process development, analytical, and cGMP manufacturing services across the drug development lifecycle.
KBI’s technologies support more than 250 drug candidates in preclinical and clinical development and 15 marketed products. KBI partners with customers to solve challenges, drive breakthroughs, and advance programs to market – serving customers from six locations across the US and Europe.
Learn more at www.kbibiopharma.com.